Roivant Sciences (ROIV) Free Cash Flow (2020 - 2026)

Roivant Sciences (ROIV) has reported Free Cash Flow for 7 consecutive years, with -$268.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow fell 28.89% year-over-year to -$268.6 million; the trailing twelve-month figure through Jun 2026 stood at -$1.3 billion (up 5.72% YoY), and the FY2026 full-year result was -$758.6 million, up 10.57% from the prior year.
• Free Cash Flow climbed to -$268.6 million in Q2 2026 per ROIV's latest filing, from -$593.5 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$192.7 million in Q3 2022 and bottomed at -$675.4 million in Q4 2022.
• Historically, Free Cash Flow has averaged -$356.1 million across 5 years, with a median of -$259.5 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow plunged 80.85% in 2022, then gained 27.74% in 2025.
• Over 5 years, Free Cash Flow stood at -$675.4 million in 2022, then gained by 2.6% to -$657.8 million in 2023, then decreased by 1.95% to -$670.7 million in 2024, then gained by 11.51% to -$593.5 million in 2025, then soared by 54.74% to -$268.6 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$268.6 million, -$593.5 million, and -$193.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.